British pharmaceutical company GSK is turning to patient data gathered from the 88 million residents of the Greater Bay Area’s 11 cities to speed up drug development in vaccines and cancer care, as officials push for closer cross-border medical cooperation. GSK Hong Kong and Macau general manager Nicholas Teo said patient data was very important because it could form “supplementary evidence” to support regulatory filings and potential label expansions, and also help to “discover benefits other...
UPVOTERS
Community appreciation
See who found this content valuable and showed their support.
No upvotes yet.
Be the first to show your appreciation for this content.
TOPICS
Explore the same topics
Discover more content from the topics this post is mapped to.
Keep browsing
Explore more from this topic
Dive into the full feed of curated posts covering Automotive News & Trends.
Discussion
Say something first
It all starts with you—share your thoughts now.